(Q45804873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Trial with human leucocyte interferon and vidarabine in herpes simplex virus encephalitis: diagnostic and therapeutic problems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

main subject

herpesviral encephalitis

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

24 August 2023

author name string

M. L. Koskiniemi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

A. Vaheri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

S. Valtonen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

M. Haltia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

M. Kaste

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

V. Manninen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

E. M. Salonen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

A. Icén

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

K. Cantell

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6188331

24 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6188331

24 August 2023

publication date

1 January 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.0954-6820.1982.tb08538.x

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1982.tb08538.x/fullpdf

24 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Acta medica Scandinavica. Supplementum

24 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

668

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

150-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

Acute necrotizing encephalitis: a problem in diagnosis

28 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Experimental herpes simplex virus encephalitis. Effect of corticosteroids and pyrimidine nucleoside

24 August 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Interferon therapy: Pharmacokinetic and pharmacological aspects

24 August 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity

24 August 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Large-scale Production of Human Leukocyte Interferon Containing 108 Units per ml

24 August 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

THE SIGNIFICANCE OF PERIODIC LATERALIZED EPILEPTIFORM DISCHARGES IN EEG: AN ELECTROGRAPHIC, CLINICAL AND PATHOLOGICAL STUDY.

24 August 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Immunochemical estimation of IgG and albumin in cerebrospinal fluid

24 August 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Fatal vidarabine toxicity in a patient with normal renal function

24 August 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

24 August 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Computerized tomography in brain biopsy-proven herpes simplex encephalitis. Early normal results

24 August 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Thymidine Kinase Activity in Cerebrospinal Fluid of Rabbits with Herpesvirus hominis Encephalitis

24 August 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Drug therapy: antiviral agents (second of two parts).

24 August 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Effect of Long-Term Treatment with Human Leukocyte Interferon on Various Laboratory Parameters

24 August 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes simplex encephalitis. The course in five virologically proven cases

24 August 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes simplex virus infections of the nervous system. Problems in laboratory diagnosis

24 August 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes Simplex Virus Encephalitis New Diagnostic and Clinical Features and Results of Therapy

24 August 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis

24 August 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes-simplex-virus encephalitis: its possible association with reactivated latent infection

24 August 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Simultaneous Serum and CSF Antibodies in Herpes Simplex Virus Encephalitis

24 August 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer

24 August 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpesvirus infections of the human central nervous system

24 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Encephalitis associated with herpes simplex virus

24 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

24 August 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Rapid solid-phase enzyme immunoassay for antibodies to viruses and other microbes: effects of polyethylene glycol

24 August 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Activation of Latent Herpes Simplex Encephalitis by Chemical Means

24 August 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Production of interferon by human leukocytes in vitro

24 August 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Combination therapy of dendritic keratitis with trifluorothymidine and interferon

24 August 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes simplex encephalitis treated with vidarabine (adenine arabinoside)

24 August 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

24 August 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes simplex encephalitis: vidarabine therapy and diagnostic problems

24 August 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

Herpes simplex encephalitis. Clinical Assessment

24 August 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.0954-6820.1982.TB08538.X

24 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6188331%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference